Tumor cells often present increased ADAM17 expression leading to autocrine EGFR activation (Dong et al, 1999; Borrell-Pagès et al, 2003; Gschwind et al, 2003; Schumacher & Rose-John, 2022). Here, EGFR is linked to neoplasm.